1. Home
  2. UEC vs PRAX Comparison

UEC vs PRAX Comparison

Compare UEC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Energy Corp.

UEC

Uranium Energy Corp.

HOLD

Current Price

$14.50

Market Cap

9.0B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$322.50

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEC
PRAX
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.6B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
UEC
PRAX
Price
$14.50
$322.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
15
Target Price
$15.80
$572.13
AVG Volume (30 Days)
7.8M
364.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,837,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$144.72
$6,395.88
P/E Ratio
N/A
N/A
Revenue Growth
29737.95
N/A
52 Week Low
$3.85
$26.70
52 Week High
$20.34
$354.87

Technical Indicators

Market Signals
Indicator
UEC
PRAX
Relative Strength Index (RSI) 44.18 53.34
Support Level $14.38 $290.36
Resistance Level $16.63 N/A
Average True Range (ATR) 1.00 18.05
MACD -0.17 -2.59
Stochastic Oscillator 42.42 56.62

Price Performance

Historical Comparison
UEC
PRAX

About UEC Uranium Energy Corp.

Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: